Document Detail

Homocysteine levels and the metabolic syndrome in a Mediterranean population: a case-control study.
MedLine Citation:
PMID:  21321409     Owner:  NLM     Status:  MEDLINE    
Hyperhomocysteinemia (HH) and metabolic syndrome (MS) are associated with increased cardiovascular risk. However, whether there is a link between MS or its components and homocysteine levels in a population without cardiovascular disease is not well established. We conducted a case-control study in 61 MS patients (41 males, 20 females, aged 51 ± 11 years) and in 98 controls without MS (59 males, 39 females, aged 50 ± 10 years) to ascertain the association between MS and HH, and with inflammatory markers. MS was classified according to the updated ATPIII criteria [17]. No differences in homocysteine levels were observed when comparing MS patients and controls (12.0 ± 3.18 μM vs. 11.9 ± 3.5 μM, p = 0.829). No association was found between HH (homocysteine >15 μM) and MS, its components (abdominal obesity (p = 0.635), hypertension (0.229), low-HDL cholesterol (p = 0.491), glucose >100 mg/dL (0.485), hypertriglyceridemia (p = 0.490)) or the number of MS components (p = 272). When considering glucose >110 mg/dL (NCEP-ATPIII criteria, 2001) instead of glucose intolerancen >100 mg/dl (updated ATPIII criteria, Grundy, 2005), a borderline association with HH was observed (p = 0.054) of statistical significance (p = 0.008) when glucose >126 mg/dL was considered. In a multivariate regression model, creatinine, folic acid and vitamin B12 were the only independent predictors of homocysteine levels (p < 0.05). Although MS correlated with inflammatory parameters (fibrinogen, hs-RCP, plasma viscosity and leukocyte count, p < 0.001), no association was found between HH and the above-mentioned parameters (p > 0.05). Our results do not indicate a link between SM or its individual components with HH, and diabetes was the only relevant contribution. Cardiovascular disease risk due to MS and HH seems to share no common mechanisms.
Amparo Vayá; Pilar Carmona; Natalia Badia; Rafael Pérez; Antonio Hernandez Mijares; Dolores Corella
Related Documents :
1516499 - Effect of glycemic control on growth velocity in children with iddm.
22768899 - The role of self-monitoring of blood glucose in glucagon-like peptide-1-based treatment...
1320459 - Insulin and progesterone increase 32po4-labeling of phospholipids and inositol 1,4,5-tr...
17550219 - Development of diabetes mellitus in two boys after the initiation of growth hormone the...
2958269 - Inhibition of somatomedin-like activity by serum from streptozotocin-diabetic rats: pre...
22411919 - Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clin...
20852089 - Rapid reduction of severely elevated serum triglycerides with insulin infusion, gemfibr...
16054099 - Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-co...
4017199 - Diabetes-induced alterations in the translational activity of specific messenger ribonu...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical hemorheology and microcirculation     Volume:  47     ISSN:  1875-8622     ISO Abbreviation:  Clin. Hemorheol. Microcirc.     Publication Date:  2011  
Date Detail:
Created Date:  2011-02-15     Completed Date:  2011-05-24     Revised Date:  2012-01-31    
Medline Journal Info:
Nlm Unique ID:  9709206     Medline TA:  Clin Hemorheol Microcirc     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  59-66     Citation Subset:  IM    
Hemorheology and Hemostasis Unit, Service of Clinical Pathology, La Fe University Hospital, Valencia, Spain. vaya
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiovascular Diseases / etiology*
Case-Control Studies
Homocysteine / blood*
Hyperhomocysteinemia / blood,  complications*
Metabolic Syndrome X / blood,  complications*
Middle Aged
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hyperhomocysteinemia, obesity and cryptogenic stroke.
Next Document:  The effect of aging on blood and plasma viscosity. An 11.6 years follow-up study.